Ledger.Open graph →
SEC Form D · Amendment · filed May 13, 2021

AEON Biopharma, Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWPORT BEACH, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Darren O'Brien · Newport Beach, CADirectorMarc Forth · Newport Beach, CAExecRichard Taketa · Newport Beach, CADirectorChris Carr · Newport Beach, CAExecJost Fischer · Newport Beach, CADirectorScott Akamine · Newport Beach, CAExecRobert Grant · Newport Beach, CADirectorSimone Blank · Newport Beach, CADirectorVikram Malik · Newport Beach, CADirectorJamie Magyera · NEW YORK, NYExecDavid Z. Chang · Cumming, GADirectorDonald Lacey · NEW YORK, NYDirectorTodd B. Myers · NEW YORK, NYExecJohn B. Robertshaw · NEW YORK, NYExecCharles Hultman · McLean, VADirectorTom B. Fortin · NEW YORK, NYDirectorGary P. Bechtel · Grand Rapids, MIDirectorRichard Taketa · Newport Beach, CADirectorStuart M. Shroyer · Cincinnati, OHExecBenjamin D. Rankin · Birmingham, ALDirectorBrian D. Johnson · La Porte, INExecRobert E. Davis · Cranberry Twp., PAExecLee Ann D. Hartinger · Cincinnati, OHDirectorMichael B. Robinson · Grand Cayman, Cayman IslandsDirectorTodd Groome · Grand Cayman, Cayman IslandsDirectorMichael E. Edleson · Grand Cayman, Cayman IslandsDirectorTimothy Sweeting · Grand Cayman, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗